Uncategorized
Anti-VEGF effective in wet AMD, diabetic retinopathy
SEATTLE — Patients diagnosed with both neovascular age-related macular degeneration and diabetic retinopathy who received intravitreal injections showed stabilization in best-corrected visual acuity and reduction in central macular thickness, according to a poster presented here. “Long-term analysis of intravitreal anti-VEGF therapy for eyes with both neovascular AMD and DR showed stabilization of BCVA and a reduction in CMT, along with stable or improved DR throughout follow-up,” Lea Querques, MD, said at the Association for Research in Vision and Ophthalmology meeting.